WebMar 9, 2024 · Introduction. Osteoporosis, as a non-specific bone disease, always occurs in middle-aged and elderly people. Patients are prone to fractures, which seriously endangers their health and affects their quality of life (Harvey et al., 2010).In recent years, an increasing number of osteoporosis prevention and treatment measures have been adopted, mainly … WebDec 6, 2024 · These include: Alendronate (Fosamax), a weekly pill. Risedronate (Actonel), a weekly or monthly pill. Ibandronate (Boniva), a monthly pill or quarterly intravenous (IV) …

Denosumab - Wikipedia

WebAug 21, 2024 · Too much thyroid hormone can cause bone loss. This can occur if your thyroid is overactive or if you take too much thyroid hormone medication to treat an underactive thyroid. Other glands. Osteoporosis … WebSeveral are potent inhibitors of bone destruction (resorption) and are in clinical use for the treatment and prevention of osteoporosis, Paget's disease, hypercalcemia caused by malignancy, tumor metastases in bone, and other bone ailments. Selective action on bone is based on the binding of the BP moiety to the bone mineral. mental health text line uk

Bisphosphonates - mechanisms of action - Australian Prescriber

WebMar 7, 2024 · This topic review provides an overview of the pharmacology of the bisphosphonates and of the differences between the preparations that are either currently … WebPurpose of review: The purpose of the review is to provide an update on recent advances in the evidence based on proton pump inhibitors (PPI) as a possible cause of osteoporosis … WebOsteoporosis medications are subdivided into two main groups: non-hormonal medications, which include bisphosphonates and denosumab; and hormonal modulators, which include teriparatide, calcitonin, and raloxifene. First, let’s start with bisphosphonates, which are first-line therapy for the prevention and treatment of osteoporosis. mental health themes by month